IBDEI1C2 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22662,0)
 ;;=A15.0^^87^983^84
 ;;^UTILITY(U,$J,358.3,22662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22662,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,22662,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,22662,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,22663,0)
 ;;=B20.^^87^983^31
 ;;^UTILITY(U,$J,358.3,22663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22663,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,22663,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,22663,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,22664,0)
 ;;=B02.9^^87^983^93
 ;;^UTILITY(U,$J,358.3,22664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22664,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,22664,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,22664,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,22665,0)
 ;;=A60.9^^87^983^2
 ;;^UTILITY(U,$J,358.3,22665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22665,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,22665,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,22665,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,22666,0)
 ;;=A60.04^^87^983^34
 ;;^UTILITY(U,$J,358.3,22666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22666,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,22666,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,22666,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,22667,0)
 ;;=A60.01^^87^983^32
 ;;^UTILITY(U,$J,358.3,22667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22667,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,22667,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,22667,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,22668,0)
 ;;=B00.1^^87^983^33
 ;;^UTILITY(U,$J,358.3,22668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22668,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,22668,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,22668,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,22669,0)
 ;;=B97.89^^87^983^89
 ;;^UTILITY(U,$J,358.3,22669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22669,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,22669,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,22669,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,22670,0)
 ;;=B97.10^^87^983^21
 ;;^UTILITY(U,$J,358.3,22670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22670,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,22670,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,22670,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,22671,0)
 ;;=B34.9^^87^983^90
 ;;^UTILITY(U,$J,358.3,22671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22671,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,22671,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,22671,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,22672,0)
 ;;=A69.20^^87^983^50
 ;;^UTILITY(U,$J,358.3,22672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22672,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,22672,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,22672,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,22673,0)
 ;;=A69.22^^87^983^52
 ;;^UTILITY(U,$J,358.3,22673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22673,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,22673,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,22673,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,22674,0)
 ;;=A69.21^^87^983^51
 ;;^UTILITY(U,$J,358.3,22674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22674,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,22674,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,22674,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,22675,0)
 ;;=A69.29^^87^983^18
 ;;^UTILITY(U,$J,358.3,22675,1,0)
 ;;=^358.31IA^4^2
